The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaxCyte Regulatory News (MXCT)

Share Price Information for MaxCyte (MXCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 290.00
Bid: 300.00
Ask: 310.00
Change: -7.00 (-2.36%)
Spread: 10.00 (3.333%)
Open: 300.00
High: 290.00
Low: 290.00
Prev. Close: 297.00
MXCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TR-1: Notification of major holdings

26 Feb 2024 07:00

RNS Number : 3519E
MaxCyte, Inc.
26 February 2024
 

TR-1: Notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

MAXCYTE INC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

X

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

 X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify) iii:

3. Details of person subject to the notification obligation iv

Name

BlackRock, Inc.

City and country of registered office (if applicable)

Wilmington, DE, USA

4. Full name of shareholder(s) (if different from 3.) v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reached vi:

22/02/2024

6. Date on which issuer notified (DD/MM/YYYY):

23/02/2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

7.98%

0.32%

8.30%

8,642,787

Position of previous notification (if

applicable)

7.85%

0.35%

8.20%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

 (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

US57777K1060

8,305,448

7.98%

SUBTOTAL 8. A

8,305,448

7.98%

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

Securities Lending

N/A

N/A

337,339

0.32%

SUBTOTAL 8. B 1

337,339

0.32%

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights

 

SUBTOTAL 8.B.2

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

X

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

BlackRock, Inc.

Trident Merger, LLC

BlackRock Investment Management, LLC

BlackRock, Inc.

BlackRock Holdco 2, Inc.

BlackRock Financial Management, Inc.

BlackRock International Holdings, Inc.

BR Jersey International Holdings L.P.

BlackRock Holdco 3, LLC

BlackRock Cayman 1 LP

BlackRock Cayman West Bay Finco Limited

BlackRock Cayman West Bay IV Limited

BlackRock Group Limited

BlackRock Finance Europe Limited

BlackRock Investment Management (UK) Limited

BlackRock, Inc.

BlackRock Holdco 2, Inc.

BlackRock Financial Management, Inc.

BlackRock Holdco 4, LLC

BlackRock Holdco 6, LLC

BlackRock Delaware Holdings Inc.

BlackRock Institutional Trust Company, National Association

BlackRock, Inc.

BlackRock Holdco 2, Inc.

BlackRock Financial Management, Inc.

BlackRock Holdco 4, LLC

BlackRock Holdco 6, LLC

BlackRock Delaware Holdings Inc.

BlackRock Fund Advisors

3.66%

0.27%

3.94%

BlackRock, Inc.

BlackRock Holdco 2, Inc.

BlackRock Financial Management, Inc.

BlackRock, Inc.

BlackRock Holdco 2, Inc.

BlackRock Financial Management, Inc.

BlackRock International Holdings, Inc.

BlackRock Canada Holdings ULC

BlackRock Asset Management Canada Limited

BlackRock, Inc.

BlackRock Holdco 2, Inc.

BlackRock Financial Management, Inc.

BlackRock Capital Holdings, Inc.

BlackRock Advisors, LLC

BlackRock, Inc.

BlackRock Holdco 2, Inc.

BlackRock Financial Management, Inc.

BlackRock International Holdings, Inc.

BR Jersey International Holdings L.P.

BlackRock Holdco 3, LLC

BlackRock Cayman 1 LP

BlackRock Cayman West Bay Finco Limited

BlackRock Cayman West Bay IV Limited

BlackRock Group Limited

BlackRock Finance Europe Limited

BlackRock Advisors (UK) Limited

BlackRock, Inc.

Trident Merger, LLC

BlackRock Investment Management, LLC

Amethyst Intermediate, LLC

Aperio Holdings, LLC

Aperio Group, LLC

 

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information xvi

 

BlackRock Regulatory Threshold Reporting Team Jana Blumenstein

020 7743 3650

 

 

Place of completion

12 Throgmorton Avenue, London, EC2N 2DL, U.K.

Date of completion

23 February 2024

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEAPASALKLEFA
Date   Source Headline
23rd Oct 20197:01 amRNSPresentations at Cell & Gene Therapy Congress
8th Oct 20197:00 amRNSNotification of AGM and Audit Declaration
7th Oct 20197:00 amRNSEditas Clinical and Commercial License Agreement
30th Sep 20197:00 amRNSUpdates on CARMA Platform at Upcoming Meetings
18th Sep 20197:00 amRNSResults for the Six Months ended 30 June 2019
9th Sep 20197:00 amRNSPresentation at ICLE 2019
14th Aug 20197:00 amRNSNotice of Results
17th Jul 20197:00 amRNSTrading Update
11th Jul 20197:00 amRNSMaxCyte to Host Capital Markets Day Today
5th Jul 20194:42 pmRNSSecond Price Monitoring Extn
5th Jul 20194:36 pmRNSPrice Monitoring Extension
19th Jun 20197:00 amRNSAnnual Report
12th Jun 20197:00 amRNSAppointment of Joint Corporate Broker
29th May 20197:00 amRNSSave the Date: Capital Markets Day
8th May 20194:41 pmRNSSecond Price Monitoring Extn
8th May 20194:36 pmRNSPrice Monitoring Extension
8th May 20197:00 amRNSPhase I Clinical Trial of MCY-M11 Progressed
1st May 20197:00 amRNSASGCT Presentation on First CARMA Drug Candidate
24th Apr 20197:00 amRNSFinal Results for Year Ended 31 December 2018
8th Apr 20197:00 amRNSLaunch of ExPERTT Instrument Family
26th Mar 20197:00 amRNSNotice of Full Year Results
19th Mar 20195:05 pmRNSDirector Dealings
5th Mar 20197:00 amRNSGrant of Options
1st Mar 20197:00 amRNSClinical & Commercial Agreement with Kite
26th Feb 20195:32 pmRNSResult of Special Meeting and Issue of Equity
5th Feb 20194:32 pmRNSResults of Placing
5th Feb 20197:00 amRNSProposed Placing to raise a minimum of £10 million
15th Jan 20197:00 amRNSTrading Update
19th Dec 20187:00 amRNSChange of Auditor
17th Dec 20186:06 pmRNSDirector Dealings
21st Nov 20187:00 amRNSConsolidation of Trading Lines
20th Nov 20187:00 amRNSBlock Admission Six Monthly Return/TVR
16th Nov 20187:00 amRNSWebinar: non-viral cell engineering
14th Nov 20187:00 amRNSClinical and Commercial License Agreement
12th Nov 20187:00 amRNSMaxCyte Announces Research Agreement with Kite
9th Nov 20187:00 amRNSExpansion of CRISPR Commercial License Agreement
31st Oct 20184:25 pmRNSResult of AGM
10th Oct 20187:00 amRNSDosing Begins in First Clinical Trial of MCY-M11
8th Oct 20187:00 amRNSNotice of AGM
24th Sep 20187:00 amRNSResults for the Half Year ended 30 June 2018
10th Sep 20187:00 amRNSGrant of Options
3rd Sep 20187:00 amRNSNotice of Half Year Results
26th Jul 20185:33 pmRNSDirector/PDMR Shareholding
16th Jul 20187:00 amRNSFDA IND Clearance for First Clinical Programme
16th Jul 20187:00 amRNSTrading Update
11th Jun 20187:00 amRNSMaxCyte & NIH enter CRADA for Sickle Cell Disease
21st May 20187:00 amRNSPreclinical Results at ASGCT Annual Meeting
30th Apr 20187:00 amRNSNotice of AGM and Annual Report
25th Apr 20187:00 amRNSCMO Appointment
4th Apr 20187:00 amRNSFinal Results for Year Ended 31 December 2017

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.